CURR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 Aug 2023 @ 15:04):

Stats
Today's Volume	1 250.00
Average Volume	17 656.00
Market Cap	8.21M
EPS	$-0.0308 ( 2023-09-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.523
ATR14	$0.0330 (30.00%)

Insider Trading

Date	Person	Action	Amount	type
2022-09-23	Salkind Gene Z	Buy	117 647	Common Stock
2021-09-23	Salkind Gene Z	Buy	117 647	Restricted Stock Unit
2023-08-17	Salkind Gene Z	Buy	186 364	Restricted Stock Unit
2023-08-17	Bagg Gerald	Buy	186 364	Restricted Stock Unit
2023-08-17	Costantino Robert J	Buy	186 364	Restricted Stock Unit

INSIDER POWER
100.00
Last 90 transactions
Buy: 9 233 498 \| Sell: 208 150

Volume Correlation

Long: 0.25 (neutral)

Short: -0.43 (neutral)

Signal:(51.795) Neutral

CURE Pharmaceutical Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CURE Pharmaceutical Correlation - Currency/Commodity

-0.71
( moderate negative )

-0.67
( moderate negative )

0.00
( neutral )

-0.66
( moderate negative )

0.00
( neutral )

0.45
( neutral )

CURE Pharmaceutical Financials

Annual	2022
Revenue:	$4.90M
Gross Profit:	$3.34M (68.20 %)
EPS:	$-0.0912

FY	2022
Revenue:	$4.90M
Gross Profit:	$3.34M (68.20 %)
EPS:	$-0.0912

FY	2021
Revenue:	$6.56M
Gross Profit:	$4.38M (66.85 %)
EPS:	$-0.260

FY	2020
Revenue:	$2.05M
Gross Profit:	$975 000 (47.54 %)
EPS:	$-0.650

Financial Reports:

No articles found.

CURE Pharmaceutical

CURE Pharmaceutical Holding Corp., a biopharmaceutical company, focuses on the development and manufacturing of drug formulation and drug delivery technologies to enhance drug safety, efficacy, and patient adherence. It operates through two segments, Cure and Sera Labs. The company's pharmaceutical drug programs include CUREfilm Blue, a sildenafil oral thin film (OTF) for the treatment of erectile dysfunction; CUREfilm Canna, a cannabinoid product with optimized pharmacokinetic profiles using microCURE and CUREfilm technology; CUREfilm Anti-Viral, an orally bio-available anti-viral of an existing therapeutic leveraging existing pre-clinical/clinical safety and toxicity data; and CUREfilm Central Nervous System, a novel dosage form to treat mental health disorders, such as depression, PTSD, addiction disorders, obsessive compulsive disorders, and anxiety. It also sells various wellness products under its distribution partners' brands. In addition, the company develops 50,000IU and Vitamin D3 OTF for oral administration. It has a licensing agreement with Canopy Growth Corporation. The company was founded in 2011 and is headquartered in Oxnard, California.